vTv Therapeutics

VTVTNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$125.735 M

$31.80 +1.27%

Close of 18 Sept 2026

Revenue

$0.00

#3639 by revenue

Earnings

-$27.0M

Loss-making

Shares outstanding

—

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 499 →

#292Biomea FusionBMEA$132.6M
#293Inovio PharmaceuticalsINO$128.2M
#294vTv TherapeuticsVTVT$125.7M
#295ProMIS NeurosciencesPMN$125.6M
#296EquilliumEQ$121.7M

What if vTv Therapeutics were worth as much as…

Open the what-if tool →

Gold $30.4T

$7,685,385

Per share 241,679× higher

Bitcoin $1.64T

$413,772.81

Per share 13,012× higher

Nvidia $5.36T

$1,354,781

Per share 42,603× higher

Or at a round number

$200.0M $500.0M $1.00B $2.00B

Where these numbers come from

Share counts and financials for vTv Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 19 Sept 2026. Read the methodology.